Our focus on the life sciences
We are an international life sciences investor. Our portfolio includes private and publicly held companies at all stages of development from start-ups to mature enterprises. We leverage our healthcare heritage to provide capital, know-how, and a valuable network to our portfolio companies.
Healthcare
Our teams invest across various healthcare subsectors. We focus on innovative companies developing new or improved medical therapies, or solutions to increase quality, improve efficiency or lower costs in healthcare.
Life Science Key Figures
€4.6bn
Deployed into life sciences in 2024
300+
Life science investments since 1999
43
New companies added to our Investment Portfolio in 2024
News
11/11/2025
Novo Holdings builds growing quantum investment portfolio, now reaching €100 million
Read more
News
11/3/2025
Novo Holdings appoints Helle Bach as Chief People Officer
Read more
News
10/29/2025
Novo Holdings portfolio company Clario to be acquired by Thermo Fisher Scientific
Read more
News
10/27/2025
Hemab Therapeutics raises $157 million in Series C financing with continued support from Novo Holdings
Read more